Five years after German patients were first allowed to obtain medical cannabis, demand has risen sharply but there are still some unanswered issues on policy and practice that lobbyists want addressed.

A unanimous decision by lawmakers in the Bundestag permitted doctors to prescribe medical cannabis from 10th March 2017. “The law was a big step forward, but now it is time for improvements,” said Armin Prasch, a board member of Germany’s Cannabis Business Industry Association (Branchenverband Cannabiswirtschaft, BvCW).

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

VIEW REPORTS

Request a free sample of this report:

“ So far so good, but German lawmakers urged to go further on medical cannabis ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ So far so good, but German lawmakers urged to go further on medical cannabis ”






      Five years after German patients were first allowed to obtain medical cannabis, demand has risen sharply but there are still some unanswered issues on policy and practice that lobbyists want addressed.

      A unanimous decision by lawmakers in the Bundestag permitted doctors to prescribe medical cannabis from 10th March 2017. “The law was a big step forward, but now it is time for improvements,” said Armin Prasch, a board member of Germany’s Cannabis Business Industry Association (Branchenverband Cannabiswirtschaft, BvCW).

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik